- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04137445
The Effects of Early Complementary Feeding on Growth, Neurodevelopment, Sleep and Gut Health
The overall objective of this project is to understand how consuming a prescribed diet of different infant foods (which may contain cereals,fruits, vegetables, meats, dairy) during the time of early complementary feeding (~5 to 12 months) in breastfed infants has on growth trajectories, neurodevelopment and sleep patterns in relation to gut microbiota, compared with a traditional diet that is usually provided in the home to infants.
The three primary aims include:
Aim 1: Identify the effects that the prescribed early complementary feeding specific study diet has on growth trajectories in breastfed infants.
Aim 2: Identify whether the relationship between the prescribed early complementary feeding specific study diet and growth is mediated by gut microbiota.
Aim 3: Characterize infant neurodevelopment and sleep patterns.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of Colorado Anschutz Medical Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Full term: gestational age > 37 weeks
- Exclusively breastfed (< 2 weeks of cumulative formula exposure). Any formula consumption on a given day is considered one day of formula exposure. During the intervention, if the participant receives more than 50% of the liquid diet from infant formula, s/he will be excluded from the study.
- Maternal conditions such as gestational diabetes mellitus, preeclampsia, multiple pregnancies are acceptable.
Exclusion Criteria:
- Large for gestational age or small for gestational age
- Antibiotic use from birth to the time of enrollment
- Documented food allergies
- Previous complementary food exposure
- Conditions that would affect protein metabolism or growth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Study Provided Diet
A group of complementary foods provided to participants by researchers.
|
Commercially available baby foods
|
|
PLACEBO_COMPARATOR: Traditional Diet
No study foods provided to participants by researchers.
Participants will eat a typical diet provided by caregivers.
|
Caregiver will provide participant with usual foods from the home
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Over 6 months
|
Measured in kg
|
Over 6 months
|
|
Length
Time Frame: Over 6 months
|
Measured in cm
|
Over 6 months
|
|
Gut Microbiome
Time Frame: Over 6 months
|
Gut microbiota structure by 16S sequencing
|
Over 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: Over 6 months
|
Body fat mass, fat-free mass measured by stable isotopes
|
Over 6 months
|
|
Total calories in breast milk
Time Frame: Over 6 months
|
Measured in kcal/100 mL
|
Over 6 months
|
|
Total carbohydrates in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
|
Total protein in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
|
Total fat in breast milk
Time Frame: Over 6 months
|
Measured in g/100 mL
|
Over 6 months
|
|
Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)
Time Frame: Over 6 months
|
Measured in ng/mL
|
Over 6 months
|
|
Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)
Time Frame: Over 6 months
|
Measured in ng/mL
|
Over 6 months
|
|
Serum c-reactive protein (CRP-hs)
Time Frame: Over 6 months
|
Measured in mg/L
|
Over 6 months
|
|
Dietary intake
Time Frame: Over 6 months
|
3 day dietary recall with results generated by NDSR software
|
Over 6 months
|
|
Neurodevelopment
Time Frame: At 12 months of age
|
Fine motor skills and cognition measured by the Bayley - III
|
At 12 months of age
|
|
Duration of sleep
Time Frame: Over 6 months
|
Measured in minutes per 24 hours by the MicroMini-Motionlogger actigraph
|
Over 6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 19-0546
- R01DK126710 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gut Microbiome
-
Ocean Spray Cranberries, Inc.RecruitingGut Microbiome | Vaginal Microbiome | Gut HealthUnited States
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
University Hospital, AntwerpActive, not recruitingGut Microbiome | Intermittent Fasting | Vaginal MicrobiomeBelgium
-
Institut National de la Santé Et de la Recherche...Recruiting
-
San Diego State UniversityRecruiting
-
University College CorkAIT Austrian Institute of Technology GmbHActive, not recruiting
-
Evolve BioSystems, Inc.University of California, DavisCompletedGut MicrobiomeUnited States
-
State University of New York at BuffaloCompleted
-
Access Business GroupCompletedGut MicrobiomeUnited States
Clinical Trials on Foods from the home
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingGut Microbiome | Linear GrowthUnited States
-
Odense University HospitalNot yet recruitingMultiple Myeloma in Relapse
-
University of AlbertaAlberta Cancer FoundationCompletedHead and Neck Cancer | DysphagiaCanada
-
Kaiser PermanenteActive, not recruitingDiabetes Mellitus, Type 2United States
-
St George's, University of LondonThe Stroke Association, United KingdomCompleted
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
University of VictoriaCompleted
-
National University Health System, SingaporeNational University of SingaporeCompleted
-
Istanbul Medipol University HospitalRecruiting
-
National Center for Research Resources (NCRR)UnknownHIV InfectionsUnited States